Global Nuclear Drug for Therapeutic Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Nuclear Drug for Therapeutic Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Radium-223
  • 1.4.3 Lutetium-177
  • 1.4.4 Iodine-131
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Nuclear Drug for Therapeutic Market Share by Application: 2020 VS 2026
  • 1.5.2 Thyroid
  • 1.5.3 Bone Metastasis
  • 1.5.4 Lymphoma
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Nuclear Drug for Therapeutic Market Perspective (2015-2026)
• 2.2 Nuclear Drug for Therapeutic Growth Trends by Regions
  • 2.2.1 Nuclear Drug for Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Nuclear Drug for Therapeutic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Nuclear Drug for Therapeutic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Nuclear Drug for Therapeutic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Nuclear Drug for Therapeutic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Nuclear Drug for Therapeutic Players by Market Size
  • 3.1.1 Global Top Nuclear Drug for Therapeutic Players by Revenue (2015-2020)
  • 3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Nuclear Drug for Therapeutic Market Concentration Ratio
  • 3.2.1 Global Nuclear Drug for Therapeutic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Nuclear Drug for Therapeutic Revenue in 2019
• 3.3 Nuclear Drug for Therapeutic Key Players Head office and Area Served
• 3.4 Key Players Nuclear Drug for Therapeutic Product Solution and Service
• 3.5 Date of Enter into Nuclear Drug for Therapeutic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2015-2020)
• 4.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2021-2026)

5 Nuclear Drug for Therapeutic Breakdown Data by Application (2015-2026)

• 5.1 Global Nuclear Drug for Therapeutic Market Size by Application (2015-2020)
• 5.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Nuclear Drug for Therapeutic Market Size (2015-2020)
• 6.2 Nuclear Drug for Therapeutic Key Players in North America (2019-2020)
• 6.3 North America Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 6.4 North America Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Nuclear Drug for Therapeutic Market Size (2015-2020)
• 7.2 Nuclear Drug for Therapeutic Key Players in Europe (2019-2020)
• 7.3 Europe Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 7.4 Europe Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

8 China

• 8.1 China Nuclear Drug for Therapeutic Market Size (2015-2020)
• 8.2 Nuclear Drug for Therapeutic Key Players in China (2019-2020)
• 8.3 China Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 8.4 China Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Nuclear Drug for Therapeutic Market Size (2015-2020)
• 9.2 Nuclear Drug for Therapeutic Key Players in Japan (2019-2020)
• 9.3 Japan Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 9.4 Japan Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Nuclear Drug for Therapeutic Market Size (2015-2020)
• 10.2 Nuclear Drug for Therapeutic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

11 India

• 11.1 India Nuclear Drug for Therapeutic Market Size (2015-2020)
• 11.2 Nuclear Drug for Therapeutic Key Players in India (2019-2020)
• 11.3 India Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 11.4 India Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Nuclear Drug for Therapeutic Market Size (2015-2020)
• 12.2 Nuclear Drug for Therapeutic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Nuclear Drug for Therapeutic Market Size by Type (2015-2020)
• 12.4 Central & South America Nuclear Drug for Therapeutic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bayer
  • 13.1.1 Bayer Company Details
  • 13.1.2 Bayer Business Overview and Its Total Revenue
  • 13.1.3 Bayer Nuclear Drug for Therapeutic Introduction
  • 13.1.4 Bayer Revenue in Nuclear Drug for Therapeutic Business (2015-2020))
  • 13.1.5 Bayer Recent Development
• 13.2 Novartis
  • 13.2.1 Novartis Company Details
  • 13.2.2 Novartis Business Overview and Its Total Revenue
  • 13.2.3 Novartis Nuclear Drug for Therapeutic Introduction
  • 13.2.4 Novartis Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.2.5 Novartis Recent Development
• 13.3 China Isotope & Radiation
  • 13.3.1 China Isotope & Radiation Company Details
  • 13.3.2 China Isotope & Radiation Business Overview and Its Total Revenue
  • 13.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Introduction
  • 13.3.4 China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.3.5 China Isotope & Radiation Recent Development
• 13.4 Dongcheng
  • 13.4.1 Dongcheng Company Details
  • 13.4.2 Dongcheng Business Overview and Its Total Revenue
  • 13.4.3 Dongcheng Nuclear Drug for Therapeutic Introduction
  • 13.4.4 Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.4.5 Dongcheng Recent Development
• 13.5 Q BioMed
  • 13.5.1 Q BioMed Company Details
  • 13.5.2 Q BioMed Business Overview and Its Total Revenue
  • 13.5.3 Q BioMed Nuclear Drug for Therapeutic Introduction
  • 13.5.4 Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.5.5 Q BioMed Recent Development
• 13.6 Curium Pharmaceuticals
  • 13.6.1 Curium Pharmaceuticals Company Details
  • 13.6.2 Curium Pharmaceuticals Business Overview and Its Total Revenue
  • 13.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Introduction
  • 13.6.4 Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.6.5 Curium Pharmaceuticals Recent Development
• 13.7 Jubilant DraxImage
  • 13.7.1 Jubilant DraxImage Company Details
  • 13.7.2 Jubilant DraxImage Business Overview and Its Total Revenue
  • 13.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Introduction
  • 13.7.4 Jubilant DraxImage Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.7.5 Jubilant DraxImage Recent Development
• 13.8 Lantheus
  • 13.8.1 Lantheus Company Details
  • 13.8.2 Lantheus Business Overview and Its Total Revenue
  • 13.8.3 Lantheus Nuclear Drug for Therapeutic Introduction
  • 13.8.4 Lantheus Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.8.5 Lantheus Recent Development
• 13.9 Spectrum Pharmaceuticals
  • 13.9.1 Spectrum Pharmaceuticals Company Details
  • 13.9.2 Spectrum Pharmaceuticals Business Overview and Its Total Revenue
  • 13.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Introduction
  • 13.9.4 Spectrum Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.9.5 Spectrum Pharmaceuticals Recent Development
• 13.10 Progenics Pharmaceuticals
  • 13.10.1 Progenics Pharmaceuticals Company Details
  • 13.10.2 Progenics Pharmaceuticals Business Overview and Its Total Revenue
  • 13.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Introduction
  • 13.10.4 Progenics Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 13.10.5 Progenics Pharmaceuticals Recent Development
• 13.11 International Isotopes
  • 10.11.1 International Isotopes Company Details
  • 10.11.2 International Isotopes Business Overview and Its Total Revenue
  • 10.11.3 International Isotopes Nuclear Drug for Therapeutic Introduction
  • 10.11.4 International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2015-2020)
  • 10.11.5 International Isotopes Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer